Savara Pharmaceuticals
SVRA
#6301
Rank
HK$4.82 B
Marketcap
HK$29.29
Share price
4.72%
Change (1 day)
8.59%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -HK$2.19

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$2.18. In 2022 the company made an earnings per share (EPS) of -HK$1.94 an increase over its 2021 EPS that were of -HK$2.64.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$2.1912.97%
2022-HK$1.94-26.47%
2021-HK$2.64-59.52%
2020-HK$6.53-56.48%
2019-HK$15.002.66%
2018-HK$14.61-38.56%
2017-HK$23.78-71.06%
2016-HK$82.16-37.06%
2015-HK$130.544.35%
2014-HK$125.10-25.81%
2013-HK$168.61-8.82%
2012-HK$184.93-27.66%
2011-HK$255.64-58.41%
2010-HK$614.62-86%
2009-HK$4,3894.13%
2008-HK$4,21524%
2007-HK$3,399-35.9%
2006-HK$5,30395%
2005-HK$2,72053.85%
2004-HK$1,76844.44%
2003-HK$1,224-40%
2002-HK$2,040

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.77 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA